

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 8.86015395 |
| 2 | establishment of viral latency (GO:0019043) | 7.10056206 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 6.73067433 |
| 4 | extracellular fibril organization (GO:0043206) | 6.13563733 |
| 5 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.69341707 |
| 6 | nuclear envelope reassembly (GO:0031468) | 5.32863308 |
| 7 | mitotic nuclear envelope reassembly (GO:0007084) | 5.32863308 |
| 8 | positive regulation of actin filament depolymerization (GO:0030836) | 5.22607720 |
| 9 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 5.17056972 |
| 10 | fibril organization (GO:0097435) | 5.07315355 |
| 11 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 5.03818035 |
| 12 | sequestering of actin monomers (GO:0042989) | 4.83973203 |
| 13 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.50526817 |
| 14 | response to gravity (GO:0009629) | 4.48596387 |
| 15 | proteasome assembly (GO:0043248) | 4.44594290 |
| 16 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 4.27087203 |
| 17 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 4.19829606 |
| 18 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 4.19829606 |
| 19 | plasma membrane fusion (GO:0045026) | 4.18199136 |
| 20 | response to interferon-beta (GO:0035456) | 4.08980530 |
| 21 | protein retention in ER lumen (GO:0006621) | 4.03185622 |
| 22 | endothelial tube morphogenesis (GO:0061154) | 3.98793455 |
| 23 | morphogenesis of an endothelium (GO:0003159) | 3.98793455 |
| 24 | pattern specification involved in kidney development (GO:0061004) | 3.94944576 |
| 25 | regulation of metalloenzyme activity (GO:0048552) | 3.90835614 |
| 26 | muscle cell migration (GO:0014812) | 3.85849925 |
| 27 | actin filament depolymerization (GO:0030042) | 3.85131453 |
| 28 | type B pancreatic cell proliferation (GO:0044342) | 3.83481445 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.83348411 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.83348411 |
| 31 | DNA unwinding involved in DNA replication (GO:0006268) | 3.81541305 |
| 32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.70131969 |
| 33 | positive regulation of pseudopodium assembly (GO:0031274) | 3.61537086 |
| 34 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.60655388 |
| 35 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.58227727 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.51383012 |
| 37 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.50633184 |
| 38 | galactose catabolic process (GO:0019388) | 3.48938168 |
| 39 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.46460653 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.46279045 |
| 41 | chromosome condensation (GO:0030261) | 3.46271111 |
| 42 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.45567811 |
| 43 | DNA packaging (GO:0006323) | 3.43586614 |
| 44 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.39932611 |
| 45 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.37827345 |
| 46 | negative regulation of ligase activity (GO:0051352) | 3.32862971 |
| 47 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.32862971 |
| 48 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.31766426 |
| 49 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.31139581 |
| 50 | ribosome assembly (GO:0042255) | 3.29859473 |
| 51 | cellular copper ion homeostasis (GO:0006878) | 3.26724184 |
| 52 | regulation of pseudopodium assembly (GO:0031272) | 3.22308558 |
| 53 | cortical actin cytoskeleton organization (GO:0030866) | 3.21964633 |
| 54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.21904837 |
| 55 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.19615821 |
| 56 | barbed-end actin filament capping (GO:0051016) | 3.18231685 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.17215365 |
| 58 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.12719392 |
| 59 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.12719392 |
| 60 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.10332791 |
| 61 | glomerular visceral epithelial cell development (GO:0072015) | 3.09292360 |
| 62 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.04833259 |
| 63 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.04833259 |
| 64 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.04833259 |
| 65 | glycolytic process (GO:0006096) | 3.04325993 |
| 66 | positive regulation of protein complex disassembly (GO:0043243) | 3.03629858 |
| 67 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.02937878 |
| 68 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.02734521 |
| 69 | regulation of mitochondrial translation (GO:0070129) | 3.00871936 |
| 70 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.96325309 |
| 71 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.96325309 |
| 72 | membrane raft organization (GO:0031579) | 2.93675072 |
| 73 | AMP metabolic process (GO:0046033) | 2.93028519 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.92280071 |
| 75 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.90475375 |
| 76 | lipopolysaccharide metabolic process (GO:0008653) | 2.89854394 |
| 77 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89387917 |
| 78 | cortical cytoskeleton organization (GO:0030865) | 2.89051452 |
| 79 | endothelial cell chemotaxis (GO:0035767) | 2.88935681 |
| 80 | mesonephros development (GO:0001823) | 2.87997263 |
| 81 | peptidyl-proline hydroxylation (GO:0019511) | 2.83553568 |
| 82 | sperm motility (GO:0030317) | 2.82824521 |
| 83 | heterochromatin organization (GO:0070828) | 2.82497037 |
| 84 | cellular response to zinc ion (GO:0071294) | 2.82269919 |
| 85 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.81934858 |
| 86 | rRNA modification (GO:0000154) | 2.80667918 |
| 87 | galactose metabolic process (GO:0006012) | 2.79034037 |
| 88 | chaperone-mediated protein transport (GO:0072321) | 2.78370481 |
| 89 | xenobiotic catabolic process (GO:0042178) | 2.77296306 |
| 90 | negative regulation of mitochondrion organization (GO:0010823) | 2.76154797 |
| 91 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.75735854 |
| 92 | fibrinolysis (GO:0042730) | 2.75667157 |
| 93 | cullin deneddylation (GO:0010388) | 2.75380327 |
| 94 | protein hydroxylation (GO:0018126) | 2.75187812 |
| 95 | multicellular organism reproduction (GO:0032504) | 2.74721416 |
| 96 | glomerular epithelial cell development (GO:0072310) | 2.74299518 |
| 97 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.73278007 |
| 98 | peptidyl-proline modification (GO:0018208) | 2.72762092 |
| 99 | regulation of cilium movement (GO:0003352) | 2.70112774 |
| 100 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.69989805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.80739077 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.56863808 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.43298894 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.30373537 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.04145159 |
| 6 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.83731564 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.82118644 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.80986951 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.78439178 |
| 10 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.48298511 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.46465950 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.46152300 |
| 13 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.42755398 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.41662575 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.34151129 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.28740135 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.12076988 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.10933891 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10535684 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.10155227 |
| 21 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.04567463 |
| 22 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96189164 |
| 23 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.94573281 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.91910195 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.91650097 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87311122 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.86213446 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.82253608 |
| 29 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.82083458 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.79150079 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68320215 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65966738 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64827208 |
| 34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.63894935 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62342072 |
| 36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.61216052 |
| 37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.58926684 |
| 38 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57598829 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51040702 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49895512 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49801555 |
| 42 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.49289047 |
| 43 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.49117950 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46825778 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45090450 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.44610956 |
| 47 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.42755839 |
| 48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41884078 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.41703092 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41487497 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.37640163 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37440966 |
| 53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35220466 |
| 54 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35212500 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34949962 |
| 56 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.32571668 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30006985 |
| 58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.28708175 |
| 59 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.27566118 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27463657 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26669398 |
| 62 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.24645920 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23864359 |
| 64 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.23049897 |
| 65 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22030994 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21188182 |
| 67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19778550 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19385627 |
| 69 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.17111095 |
| 70 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16991036 |
| 71 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16991036 |
| 72 | CBP_21632823_ChIP-Seq_H3396_Human | 1.14725919 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13311660 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.12607138 |
| 75 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12312858 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12229412 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12061645 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10553327 |
| 79 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06368277 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05573888 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05131468 |
| 82 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04693565 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04226027 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03677971 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02018738 |
| 86 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01426130 |
| 87 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01165300 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01126930 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 1.00088504 |
| 90 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99364064 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98936723 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98201987 |
| 93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.98078129 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97618474 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96761503 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96511100 |
| 97 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96154320 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95445401 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93899753 |
| 100 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93750277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 4.46100410 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.09612473 |
| 3 | MP0005410_abnormal_fertilization | 4.07881971 |
| 4 | MP0003123_paternal_imprinting | 3.43729286 |
| 5 | MP0000751_myopathy | 3.36503143 |
| 6 | MP0010030_abnormal_orbit_morphology | 3.34801742 |
| 7 | MP0005257_abnormal_intraocular_pressure | 3.02972655 |
| 8 | MP0000749_muscle_degeneration | 2.96659386 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.90356811 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.71221161 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.68714327 |
| 12 | MP0005670_abnormal_white_adipose | 2.64275151 |
| 13 | MP0005165_increased_susceptibility_to | 2.58577711 |
| 14 | MP0002332_abnormal_exercise_endurance | 2.52768479 |
| 15 | MP0001542_abnormal_bone_strength | 2.44694024 |
| 16 | MP0004272_abnormal_basement_membrane | 2.37860289 |
| 17 | MP0005367_renal/urinary_system_phenotyp | 2.09141871 |
| 18 | MP0000516_abnormal_urinary_system | 2.09141871 |
| 19 | MP0003075_altered_response_to | 2.05902766 |
| 20 | MP0003566_abnormal_cell_adhesion | 2.00840304 |
| 21 | MP0005330_cardiomyopathy | 1.94697099 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.90620720 |
| 23 | MP0003315_abnormal_perineum_morphology | 1.87178855 |
| 24 | MP0000343_altered_response_to | 1.86712245 |
| 25 | MP0001853_heart_inflammation | 1.84459049 |
| 26 | MP0003786_premature_aging | 1.81687033 |
| 27 | MP0009840_abnormal_foam_cell | 1.79505683 |
| 28 | MP0003718_maternal_effect | 1.77011859 |
| 29 | MP0001299_abnormal_eye_distance/ | 1.69914080 |
| 30 | MP0003329_amyloid_beta_deposits | 1.68007357 |
| 31 | MP0009697_abnormal_copulation | 1.63757615 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.52217733 |
| 33 | MP0000858_altered_metastatic_potential | 1.50001967 |
| 34 | MP0002282_abnormal_trachea_morphology | 1.46172045 |
| 35 | MP0005360_urolithiasis | 1.42767140 |
| 36 | MP0006054_spinal_hemorrhage | 1.41550829 |
| 37 | MP0003186_abnormal_redox_activity | 1.40280337 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.39729289 |
| 39 | MP0005166_decreased_susceptibility_to | 1.30770234 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.28314641 |
| 41 | MP0009053_abnormal_anal_canal | 1.27580109 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.26086263 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.22586428 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.19527284 |
| 45 | MP0005451_abnormal_body_composition | 1.17624544 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.16908510 |
| 47 | MP0003077_abnormal_cell_cycle | 1.16248068 |
| 48 | MP0008007_abnormal_cellular_replicative | 1.15820755 |
| 49 | MP0001243_abnormal_dermal_layer | 1.15239694 |
| 50 | MP0001905_abnormal_dopamine_level | 1.14100114 |
| 51 | MP0000358_abnormal_cell_content/ | 1.13567257 |
| 52 | MP0005083_abnormal_biliary_tract | 1.12310650 |
| 53 | MP0001929_abnormal_gametogenesis | 1.11441738 |
| 54 | MP0002060_abnormal_skin_morphology | 1.11207887 |
| 55 | MP0000534_abnormal_ureter_morphology | 1.09554066 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.08748847 |
| 57 | MP0002972_abnormal_cardiac_muscle | 1.07973321 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.06637413 |
| 59 | MP0003436_decreased_susceptibility_to | 1.06517302 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.04268485 |
| 61 | MP0003698_abnormal_male_reproductive | 1.02151949 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 1.00223331 |
| 63 | MP0005197_abnormal_uvea_morphology | 0.99689266 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96914514 |
| 65 | MP0003279_aneurysm | 0.96622189 |
| 66 | MP0002177_abnormal_outer_ear | 0.93712812 |
| 67 | MP0003638_abnormal_response/metabolism_ | 0.89041772 |
| 68 | MP0008932_abnormal_embryonic_tissue | 0.87708709 |
| 69 | MP0000647_abnormal_sebaceous_gland | 0.85375311 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.83927930 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 0.83346079 |
| 72 | MP0005395_other_phenotype | 0.81882684 |
| 73 | MP0002106_abnormal_muscle_physiology | 0.80979508 |
| 74 | MP0000762_abnormal_tongue_morphology | 0.80509198 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.78596843 |
| 76 | MP0004147_increased_porphyrin_level | 0.78579786 |
| 77 | MP0005164_abnormal_response_to | 0.77632443 |
| 78 | MP0001533_abnormal_skeleton_physiology | 0.76767828 |
| 79 | MP0001346_abnormal_lacrimal_gland | 0.72173321 |
| 80 | MP0000249_abnormal_blood_vessel | 0.71651628 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.70854489 |
| 82 | MP0000613_abnormal_salivary_gland | 0.70344711 |
| 83 | MP0008260_abnormal_autophagy | 0.70296518 |
| 84 | MP0000747_muscle_weakness | 0.69275177 |
| 85 | MP0002006_tumorigenesis | 0.69197633 |
| 86 | MP0002161_abnormal_fertility/fecundity | 0.68719246 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.67699004 |
| 88 | MP0000604_amyloidosis | 0.67132708 |
| 89 | MP0005501_abnormal_skin_physiology | 0.66274337 |
| 90 | MP0002210_abnormal_sex_determination | 0.65534309 |
| 91 | MP0003091_abnormal_cell_migration | 0.65003981 |
| 92 | MP0009278_abnormal_bone_marrow | 0.62291127 |
| 93 | MP0002132_abnormal_respiratory_system | 0.61087332 |
| 94 | MP0005408_hypopigmentation | 0.60435275 |
| 95 | MP0009764_decreased_sensitivity_to | 0.60259941 |
| 96 | MP0003942_abnormal_urinary_system | 0.59380468 |
| 97 | MP0001340_abnormal_eyelid_morphology | 0.59333305 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.58080451 |
| 99 | MP0005266_abnormal_metabolism | 0.56782730 |
| 100 | MP0008469_abnormal_protein_level | 0.56410883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amyloidosis (HP:0011034) | 5.29592888 |
| 2 | Glucose intolerance (HP:0000833) | 4.87581718 |
| 3 | Upper limb muscle weakness (HP:0003484) | 4.37731091 |
| 4 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.21350666 |
| 5 | Adrenal hypoplasia (HP:0000835) | 4.03599282 |
| 6 | Premature rupture of membranes (HP:0001788) | 3.70305039 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.69209353 |
| 8 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.61319655 |
| 9 | Osteolytic defects of the hand bones (HP:0009699) | 3.61319655 |
| 10 | Distal lower limb muscle weakness (HP:0009053) | 3.53678599 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.47116478 |
| 12 | Delayed CNS myelination (HP:0002188) | 3.34952281 |
| 13 | Short nail (HP:0001799) | 3.31482925 |
| 14 | Hepatic necrosis (HP:0002605) | 3.25656491 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.22042645 |
| 16 | Insulin resistance (HP:0000855) | 3.20248197 |
| 17 | Abnormal glucose tolerance (HP:0001952) | 3.17098524 |
| 18 | Microglossia (HP:0000171) | 3.05101658 |
| 19 | Vascular calcification (HP:0004934) | 3.04853739 |
| 20 | Abnormal spermatogenesis (HP:0008669) | 2.97824380 |
| 21 | Cholecystitis (HP:0001082) | 2.97514935 |
| 22 | Abnormal gallbladder physiology (HP:0012438) | 2.97514935 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 2.95008111 |
| 24 | Entropion (HP:0000621) | 2.91505624 |
| 25 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.91123852 |
| 26 | Axonal loss (HP:0003447) | 2.90397323 |
| 27 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.89755380 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 2.81333134 |
| 29 | Rough bone trabeculation (HP:0100670) | 2.78197202 |
| 30 | Increased serum pyruvate (HP:0003542) | 2.73968571 |
| 31 | Bifid uvula (HP:0000193) | 2.73934170 |
| 32 | Distal lower limb amyotrophy (HP:0008944) | 2.72725764 |
| 33 | Flat capital femoral epiphysis (HP:0003370) | 2.71473291 |
| 34 | Reduced antithrombin III activity (HP:0001976) | 2.69780105 |
| 35 | Hand muscle atrophy (HP:0009130) | 2.64458956 |
| 36 | Cardiovascular calcification (HP:0011915) | 2.63774707 |
| 37 | Abnormality of glycolysis (HP:0004366) | 2.61755168 |
| 38 | Prolonged neonatal jaundice (HP:0006579) | 2.54865281 |
| 39 | Opisthotonus (HP:0002179) | 2.52040848 |
| 40 | Increased CSF lactate (HP:0002490) | 2.51299286 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.50902441 |
| 42 | Severe visual impairment (HP:0001141) | 2.49933278 |
| 43 | Atrophic scars (HP:0001075) | 2.44328478 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.42358771 |
| 45 | Difficulty climbing stairs (HP:0003551) | 2.42115308 |
| 46 | Limb-girdle muscle atrophy (HP:0003797) | 2.41513818 |
| 47 | Acute encephalopathy (HP:0006846) | 2.36072001 |
| 48 | Male infertility (HP:0003251) | 2.35792093 |
| 49 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.35374886 |
| 50 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.35374886 |
| 51 | Shoulder girdle muscle weakness (HP:0003547) | 2.35182566 |
| 52 | Acanthosis nigricans (HP:0000956) | 2.34151168 |
| 53 | Exertional dyspnea (HP:0002875) | 2.34100217 |
| 54 | Exercise intolerance (HP:0003546) | 2.31056033 |
| 55 | Pelvic girdle muscle weakness (HP:0003749) | 2.29155275 |
| 56 | Joint hemorrhage (HP:0005261) | 2.28078107 |
| 57 | Bradycardia (HP:0001662) | 2.27228769 |
| 58 | Progressive macrocephaly (HP:0004481) | 2.26900547 |
| 59 | Increased connective tissue (HP:0009025) | 2.25170126 |
| 60 | Late onset (HP:0003584) | 2.24922804 |
| 61 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.24242968 |
| 62 | Down-sloping shoulders (HP:0200021) | 2.23997229 |
| 63 | Sparse eyelashes (HP:0000653) | 2.23931242 |
| 64 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.19576768 |
| 65 | Myocardial infarction (HP:0001658) | 2.16781499 |
| 66 | Short clavicles (HP:0000894) | 2.16439313 |
| 67 | Hepatosplenomegaly (HP:0001433) | 2.16064436 |
| 68 | Emotional lability (HP:0000712) | 2.12727091 |
| 69 | Abnormal protein glycosylation (HP:0012346) | 2.11395411 |
| 70 | Abnormal glycosylation (HP:0012345) | 2.11395411 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.11395411 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.11395411 |
| 73 | Increased hepatocellular lipid droplets (HP:0006565) | 2.10369054 |
| 74 | Achilles tendon contracture (HP:0001771) | 2.08588140 |
| 75 | Testicular atrophy (HP:0000029) | 2.07698369 |
| 76 | Upper limb amyotrophy (HP:0009129) | 2.06437115 |
| 77 | Distal upper limb amyotrophy (HP:0007149) | 2.06437115 |
| 78 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.02637273 |
| 79 | Sclerocornea (HP:0000647) | 2.02561278 |
| 80 | Natal tooth (HP:0000695) | 2.01871332 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01862762 |
| 82 | Secondary amenorrhea (HP:0000869) | 1.99680603 |
| 83 | Hypertriglyceridemia (HP:0002155) | 1.99563041 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 1.99471391 |
| 85 | Increased serum lactate (HP:0002151) | 1.97671469 |
| 86 | Abnormality of the sella turcica (HP:0002679) | 1.97541210 |
| 87 | Fatigue (HP:0012378) | 1.96726072 |
| 88 | Myoglobinuria (HP:0002913) | 1.96168142 |
| 89 | Abnormal trabecular bone morphology (HP:0100671) | 1.94332222 |
| 90 | Flattened epiphyses (HP:0003071) | 1.92438379 |
| 91 | Severe muscular hypotonia (HP:0006829) | 1.89339044 |
| 92 | Spastic paraparesis (HP:0002313) | 1.88480635 |
| 93 | Multiple lipomas (HP:0001012) | 1.87567080 |
| 94 | Abnormal pupillary function (HP:0007686) | 1.87211005 |
| 95 | Rhabdomyolysis (HP:0003201) | 1.87172034 |
| 96 | Increased intramyocellular lipid droplets (HP:0012240) | 1.85863152 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 1.85084100 |
| 98 | Tongue fasciculations (HP:0001308) | 1.84760934 |
| 99 | Lactic acidosis (HP:0003128) | 1.84312684 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.83499783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK1 | 6.44292762 |
| 2 | VRK2 | 5.75597581 |
| 3 | TESK2 | 5.28383127 |
| 4 | NME2 | 4.71559884 |
| 5 | LIMK1 | 4.31283250 |
| 6 | ARAF | 3.40404339 |
| 7 | EPHA2 | 3.10730228 |
| 8 | PIM2 | 2.42718727 |
| 9 | BUB1 | 2.34821884 |
| 10 | LMTK2 | 2.23112361 |
| 11 | MAP2K7 | 2.04568389 |
| 12 | DAPK1 | 1.79224725 |
| 13 | IRAK3 | 1.72173025 |
| 14 | BCKDK | 1.59239742 |
| 15 | MOS | 1.58344597 |
| 16 | MST1R | 1.46542377 |
| 17 | VRK1 | 1.45368955 |
| 18 | ABL2 | 1.44097173 |
| 19 | TAOK2 | 1.34710801 |
| 20 | PAK4 | 1.32764264 |
| 21 | STK16 | 1.32639796 |
| 22 | ERN1 | 1.32108902 |
| 23 | MAP3K12 | 1.30196567 |
| 24 | STK10 | 1.28326859 |
| 25 | BRAF | 1.17884912 |
| 26 | SRPK1 | 1.16223597 |
| 27 | PLK4 | 1.15962719 |
| 28 | KDR | 1.15265140 |
| 29 | CSNK1G3 | 1.11371065 |
| 30 | PHKG1 | 1.10670589 |
| 31 | PHKG2 | 1.10670589 |
| 32 | MAP3K11 | 1.10501467 |
| 33 | CCNB1 | 1.01378540 |
| 34 | CSNK1A1L | 1.00649255 |
| 35 | PTK2B | 0.96971068 |
| 36 | NEK1 | 0.94974448 |
| 37 | TAF1 | 0.94809922 |
| 38 | ERBB4 | 0.91861552 |
| 39 | MAPKAPK3 | 0.85038681 |
| 40 | AURKA | 0.83368322 |
| 41 | HIPK2 | 0.81164044 |
| 42 | CDK19 | 0.79586280 |
| 43 | EPHB2 | 0.76399029 |
| 44 | CSNK1G2 | 0.76278131 |
| 45 | ILK | 0.75093807 |
| 46 | CSNK1G1 | 0.71872160 |
| 47 | PAK1 | 0.70891482 |
| 48 | MAP4K2 | 0.70672274 |
| 49 | PTK2 | 0.69913718 |
| 50 | MST4 | 0.69747505 |
| 51 | CDK7 | 0.69553449 |
| 52 | TBK1 | 0.69139675 |
| 53 | BRSK1 | 0.67786841 |
| 54 | CDK8 | 0.65303376 |
| 55 | GRK5 | 0.64662395 |
| 56 | MYLK | 0.64239415 |
| 57 | DAPK3 | 0.61915615 |
| 58 | SCYL2 | 0.61315492 |
| 59 | DAPK2 | 0.54516861 |
| 60 | LRRK2 | 0.53375724 |
| 61 | GRK7 | 0.49960731 |
| 62 | RAF1 | 0.48252001 |
| 63 | CDK14 | 0.46948940 |
| 64 | TGFBR2 | 0.46188832 |
| 65 | PRKCI | 0.44591805 |
| 66 | BMX | 0.43290794 |
| 67 | CDK11A | 0.42567365 |
| 68 | CDC7 | 0.42219166 |
| 69 | NUAK1 | 0.41795201 |
| 70 | PLK1 | 0.41371707 |
| 71 | MAP3K3 | 0.40385821 |
| 72 | EPHB1 | 0.40042617 |
| 73 | STK38 | 0.39265984 |
| 74 | PDK2 | 0.37664778 |
| 75 | CDK15 | 0.36469602 |
| 76 | MET | 0.36003373 |
| 77 | CDK18 | 0.35763750 |
| 78 | PRPF4B | 0.34730531 |
| 79 | MAP3K8 | 0.34007689 |
| 80 | INSRR | 0.33898980 |
| 81 | AURKB | 0.31592212 |
| 82 | MAPKAPK2 | 0.28691255 |
| 83 | EIF2AK2 | 0.27300146 |
| 84 | CAMK2G | 0.26180383 |
| 85 | RPS6KA5 | 0.26002682 |
| 86 | PLK3 | 0.25760787 |
| 87 | SMG1 | 0.24670491 |
| 88 | ROCK2 | 0.24229903 |
| 89 | ICK | 0.23870483 |
| 90 | PLK2 | 0.22680471 |
| 91 | DDR2 | 0.22368274 |
| 92 | CSNK2A2 | 0.22177778 |
| 93 | GSK3A | 0.21621896 |
| 94 | ROCK1 | 0.19869415 |
| 95 | EIF2AK1 | 0.19575173 |
| 96 | MAP3K1 | 0.19332592 |
| 97 | IKBKE | 0.17907659 |
| 98 | NEK2 | 0.16613213 |
| 99 | CAMKK2 | 0.15750695 |
| 100 | PBK | 0.14167366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.23753148 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.61472645 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.21471760 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.78044620 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.75736484 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.72165507 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.58062567 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.57235950 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.55512285 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.47603168 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.37714122 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.31184712 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.23787233 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.12252685 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00649121 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.97667694 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.97175431 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.91808027 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.86306607 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.82505535 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78898619 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.76179475 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74581768 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.68066710 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67125408 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.64356052 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.63630792 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.50431055 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49133077 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42786654 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30178630 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29658038 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29400069 |
| 34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.29113336 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.26667479 |
| 36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23750233 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19720646 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13938634 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07792167 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98036058 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97637972 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93674029 |
| 43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92557130 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88635041 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87244891 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79871393 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79622818 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 0.79462899 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78143371 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.76805329 |
| 51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76052835 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.75426309 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74802471 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74104699 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73663443 |
| 56 | Spliceosome_Homo sapiens_hsa03040 | 0.72953855 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72014693 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68985103 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.67951836 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63387019 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59177516 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55606002 |
| 63 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53890184 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.51630733 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50430195 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46685631 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.46578237 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45078932 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44922222 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.44891241 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.44515208 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44365698 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41830586 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39332081 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.37169579 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.36332724 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34972655 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33808905 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32547417 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.31690129 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30408827 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29187528 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29070352 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27989587 |
| 85 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.27897127 |
| 86 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.26257349 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25779073 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23959030 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.23809770 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.23109003 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22568015 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.21692201 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21442618 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.20290436 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19470837 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19285608 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.17045672 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.14799634 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13742579 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12587738 |

